Home
Conditions
Biliary Tract Cancer

Clinical trial condition

Biliary Tract Cancer

Explore clinical trials studying Biliary Tract Cancer. Study availability and eligibility vary by location and protocol.

168 public trials 56 recruiting studies

Refine in advanced search Browse all conditions

Biliary Tract Cancer trial results

Not yet recruiting

Adebrelimab Plus S-1 for Resected Cholangiocarcinoma

NCT07561775

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer

NCT07159217

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
Locations: Chinese Academy of Medical Sciences, Peking Union Medical College Hospital Beijing, China

View Trial Details

Not yet recruiting

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

NCT07003815

Conditions: Advanced Cancer, Biliary Tract Cancer, Biliary Tract Diseases, +5 more
Locations: Not specified

View Trial Details

Not yet recruiting

Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies

NCT06993025

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

Tianjin Cancer Hospital Airport Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not yet recruiting

A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.

NCT06654947

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Not specified

View Trial Details

Not yet recruiting

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

NCT06662877

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation

NCT06531291

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +15 more
Locations: Renji hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Consolidative Radiotherapy (CSRT) in Patients With Oligometastatic/Locally Advanced Unresectable Bilary Tract Cancer (BTC)

NCT06502080

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Zhongshan Hospital Shanghai, China

View Trial Details

Not yet recruiting

HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

NCT06389500

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Not specified

View Trial Details

Active, not recruiting

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

NCT05994001

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations: Zhongshan hospital, Fudan University Shanghai, China

View Trial Details

Biliary Tract Cancer

Biliary Tract Cancer trial results

Related conditions